Development of antibiotic loaded biodegradable matrices to prevent superficial infections associated to total knee arthroplasty

• Published in: Colloids and surfaces, B, Biointerfaces B, Biointerfaces, 2019-09, Vol.181, p.1-5
• Main Authors: Martínez-Moreno, Javier, Mir-Palomo, Silvia, Merino, Virginia, Nácher, Amparo, Merino-Sanjuán, Matilde
• Format: Article
• Language: English
• Subjects: Animals; Anti-Bacterial Agents - chemistry; Anti-Bacterial Agents - pharmacology; Arthroplasty; Arthroplasty, Replacement, Knee; Bioactivity; Cell Proliferation - drug effects; Cell Survival - drug effects; Chitosan; Chitosan - chemistry; Chitosan - pharmacology; Ciprofloxacin; Ciprofloxacin - chemistry; Ciprofloxacin - pharmacology; Elution kinetics; Fibroblasts - drug effects; Gentamicin; Gentamicins - chemistry; Gentamicins - pharmacology; Mice; NIH 3T3 Cells; Organophosphorus Compounds - chemistry; Organophosphorus Compounds - pharmacology; Orthopedics; Particle Size; Surface Properties; THPC (tetrakis-(hydroxymethyl)-phosphonium-chloride)
• ISSN: 0927-7765; 1873-4367
• DOI: 10.1016/j.colsurfb.2019.05.024

[Display omitted] •Chitosan crosslinked with THPC provides release of ciprofloxacin for six days.•Ciprofloxacin into chitosan hydrogels can be useful to treat superficial joint infections.•Chitosan hydrogels for superficial joint infections can be considered safe. Development of a pharmaceutical form for the superficial infections related with arthroplasties would be helpful for clinical practice. In this context, we set out to evaluate ciprofloxacin and gentamicin elution from systems based on chitosan. Films and semisolid hydrogels containing chitosan alone (2%) or in combination with gelatin (6%) or different proportions (from 12% to 36%) of tetrakis-(hydroxymethyl)-phosphonium-chloride (THPC) were tested as delivery systems. Different antibiotic doses were assayed (0.5 mg/cm2,1 mg/cm2 and 2 mg/cm2). Antibiotic release was studied for each formulation. In vitro cytocompatibility studies and a simulation exercise for bioactivity evaluation were performed. Samples containing chitosan or chitosan-gelatin released the antibiotics at very high rates. On the contrary, ciprofloxacin released was kept for 6 days from THPC-chitosan films and hydrogels. From hydrogel formulations release could be changed by varying the percentage of THPC. The system containing 12%-THPC-chitosan with 2 mg/cm2 of ciprofloxacin showed that 100% of patient would be covered during 72 h post-surgery. The concentration of 12%-THPC did not show cytotoxicity in NIH3T3 mouse fibroblasts after 48 h. THPC is suitable as crosslinker for chitosan when ciprofloxacin is incorporated showing a sustained release during 6 days.